You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of news articles, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• Next

• • Apr 27, 2010
  • AstraZeneca finalizes US agreement on SEROQUEL marketing  
• • Apr 21, 2010
  • AstraZeneca HealthCare Foundation announces its newest program - Connections for Cardiovascular Health℠  
• • Apr 19, 2010
  • AstraZeneca recognizes employee volunteerism  
• • Apr 16, 2010
  • AstraZeneca launches SEROQUEL XR® (quetiapine fumarate) for add-on treatment of major depressive disorder  
• • Apr 14, 2010
  • AstraZeneca donates $1 million transformational gift in support of Nemours/Alfred I. duPont Hospital for Children expansion project  
• • Apr 13, 2010
  • Catherine Bonuccelli, MD receives Delaware Bio Science Service Award  
• • Mar 30, 2010
  • AstraZeneca and Abbott receive FDA complete response letter on CERTRIAD™ New Drug Application  
• • Mar 25, 2010
  • AstraZeneca joins global Earth Hour effort  
• • Mar 18, 2010
  • Text of David Brennan’s speech at the 2010 Annual PhRMA Meeting  
• • Mar 17, 2010
  • U.S. Food and Drug Administration accepts New Drug Application for once-daily fixed dose combination of ONGLYZA™ (saxagliptin) and extended release metformin for the treatment of type 2 diabetes mellitus in adults  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed